pocketful logo
TTK Healthcare Ltd logo

TTK Healthcare Ltd

NSE: TTKHLTCARE BSE: 507747

₹908.25

(-0.89%)

Wed, 04 Mar 2026, 05:26 am

TTK Healthcare Price to Sales Ratio (P/S)

Particulars20052006200720082009201020112012201320142015201620172018201920202021202220232024
Price to earnings ratio28.9820.384.729.8121.9521.3019.4222.1032.8244.7131.6932.8581.8339.3437.5015.0528.172.2833.3520.71
Price to book ratio1.591.3811.243.084.163.463.203.806.115.273.916.383.811.862.373.551.532.091.59
Price to sales ratio0.310.290.290.350.791.010.860.820.981.501.401.172.571.530.721.471.962.012.782.11
Price to cash flow ratio6.90123.628.766.9311.5813.2378.6914.3141.3820.0921.0431.9953.1744.8118.576.2321.34042.2629.32
Enterprise value569.54M489.39M209.63M421.52M1.65B2.65B2.53B2.52B3.54B6.86B6.7B5.56B13.97B8.62B3.6B4.9B9.2B6.41B12.73B8.6B
Enterprise value to EBITDA ratio8.557.143.693.7310.5212.3110.5312.3118.2423.1218.3814.2432.6616.9212.2124.4440.1519.8632.9023.89
Debt to equity ratio0.370.290.230.240.220.160.210.230.290.350.280.150.200.110.120.060.070.030.020.02
Return on equity %07.1023.1413.1914.4021.0219.1615.2812.0814.3517.8112.769.4710.064.9213.535.936.966.437.90

TTK Healthcare Ltd Price to Sales Ratio

The TTK Healthcare Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate TTK Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the TTK Healthcare Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

TTK Healthcare Ltd (NSE: TTKHLTCARE, BSE: 507747) is currently trading at ₹908.25, with a market capitalization of ₹12.91B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the TTK Healthcare Ltd Price to Sales Ratio is essential for fundamental analysis.

TTK Healthcare Ltd Price to Sales Ratio Current Value

The current TTK Healthcare Ltd Price to Sales Ratio stands at 2.11.

The TTK Healthcare Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

TTK Healthcare Ltd Price to Sales Ratio Historical Trend

The TTK Healthcare Ltd Price to Sales Ratio has shown the following historical trend:

  • 2024: 2.11
  • 2023: 2.78
  • 2022: 2.01
  • 2021: 1.96
  • 2020: 1.47

The decline in TTK Healthcare Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What TTK Healthcare Ltd Price to Sales Ratio Indicates for Investors

The TTK Healthcare Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

TTK Healthcare Ltd Price to Sales Ratio Analysis Summary

The TTK Healthcare Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking TTK Healthcare Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of TTK Healthcare Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800